These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9631151)

  • 21. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.
    Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM
    Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
    Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
    Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].
    Kuhlmann B; Trein A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():72-3. PubMed ID: 15373057
    [No Abstract]   [Full Text] [Related]  

  • 25. Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma.
    Bower M; Powles T; Nelson M; Mandalia S; Gazzard B; Stebbing J
    J Natl Cancer Inst; 2006 Aug; 98(15):1088-91. PubMed ID: 16882946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system plasmablastic lymphoma in AIDS.
    Shuangshoti S; Assanasen T; Lerdlum S; Srikijvilaikul T; Intragumtornchai T; Thorner PS
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):245-7. PubMed ID: 17983424
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of the treatment of HIV-associated lymphoma.
    Kaplan LD
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019.
    Aboulafia DM; Ratner L; Miles SA; Harrington WJ;
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):399-402. PubMed ID: 16640817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
    Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
    J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Small bowel lymphoma detected by MiroCam capsule endoscope in a patient with acquired immune deficiency syndrome].
    Baik SJ; Shim KN; Choi HJ; Jung SA; Yoo K
    Korean J Gastroenterol; 2008 Jul; 52(1):37-41. PubMed ID: 19077490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS and lymphoma.
    TreatmentUpdate; 2001 Oct; 13(6):2-3. PubMed ID: 11768867
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of opportunistic infections and lymphoma in the nervous system.
    Loy CT; Brew BJ
    J HIV Ther; 2002 Feb; 7(1):21-5. PubMed ID: 11956501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
    Newell ME; Hoy JF; Cooper SG; DeGraaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI
    Cancer; 2004 Jun; 100(12):2627-36. PubMed ID: 15197806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated non-Hodgkin's lymphoma of the spleen: CT findings in an AIDS patient treated with highly active antiretroviral therapy.
    Stasolla A; Kharrub Z; Colaiacomo MC; Cirelli G; Cirelli A; Marini M
    Radiol Med; 2002; 104(1-2):111-4. PubMed ID: 12386565
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS-related non-Hodgkin's lymphomas from an Italian area.
    Ferretto R; Luzzati R; Veneri D; Rovere P; Solbiati M; Concia E
    Haematologica; 1998 Sep; 83(9):857-9. PubMed ID: 9825586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-associated Hodgkin lymphoma.
    Carbone A; Gloghini A; Serraino D; Spina M
    Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of AIDS-related lymphoma.
    Levine AM
    Curr Opin Oncol; 2008 Sep; 20(5):522-8. PubMed ID: 19106654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.